Geographic location of commercial plasma donation clinics in the United States, 1980-1995

American Journal of Public Health

Volumn 94, Issue 7, 2004, Pages 1224-1229

  James, Robert C ^a   Mustard, Cameron A ^a,b,c,d  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c INSTITUTE FOR WORK AND HEALTH   (Canada)

^d CANADIAN INSTITUTE FOR ADVANCED RESEARCH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; DIAMORPHINE; ILLICIT DRUG;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; DRUG ABUSE; GEOGRAPHY; HEALTH CENTER; HEPATITIS C; HIGH RISK POPULATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PLASMA CLINIC; POVERTY; RED CROSS; SOCIAL ENVIRONMENT; UNITED STATES; VIRUS TRANSMISSION;

EID: 3042777716     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.94.7.1224     Document Type: Article

References (43)

1. Feldman EA, Bayer R, eds. Blood Feuds: AIDS. Blood and the Politics of Medical Disaster. New York, NY: Oxford University Press; 1999.
2. Goedert JJ, Sarngadharan MG, Eyster ME, Weiss SH, Bodner AJ, Gallo RC, et al. Antibodies reactive with human T cell leukemia viruses in the serum of hemophiliacs receiving factor VIII concentrate. Blood. 1985; 65:492-495.
3. Report on the Global Survey 2001. Montréal, Québec: World Federation of Hemophilia; 2001.
4. Soucie JM, Nuss R, Evatt B, Abdelhak A, Cowan L, Hill H, et al. Mortality among males with hemophilia: relations with source of medical care. The Hemophilia Surveillance System Project Investigators. Blood. 2000; 96:437-442.
5. Walker IR, Julian JA. Causes of death in Canadians with haemophilia 1980-1995. Association of Hemophilia Clinic Directors of Canada. Haemophilia. 1998;4:714-720.
6. Troisi CL, Hollinger FB, Hoots WK, Contant C, Gill J, Ragni M, et al. A multicenter study of viral hepatitis in a United States hemophilic population. Blood 1993;81:412-418.
7. Yee TT, Griffioen A, Sabin CA, Dusheiko G, Lee CA. The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985. Gut. 2000; 47:845-851.
8. Weinberg PD, Hounshell J, Sherman LA, Godwin J, Ali S, Tomori C, et al. Legal, financial, and public health consequences of HIV contamination of blood and blood products in the 1980s and 1990s. Ann Intern Med. 2002;136:312-319.
9. Commission of Inquiry on the Blood System in Canada. Final Report. Ottawa, Ontario: Commission of Inquiry on the Blood System in Canada; 1997.
10. RCMP Blood Task Force. Ottawa, Ontario: Royal Canadian Mounted Police; 2001. Available at: http://www.rcmp-grc.gc.ca/html/bloodtaskforce_e.htm [accessed October 9, 2003].
11. General Accounting Office. Blood Safety: Enhancing Safeguards Would Strengthen the Nation's Blood Supply. Washington, DC: US General Accounting Office; June 5, 1997. GAO/HEHS-97-143.
12. Titmuss RM. The Gift Relationship: From Human Blood to Social Policy. London: Allen & Unwin; 1971.
13. Shilts R. And the Band Played On: Politics, People, and the AIDS Epidemic. New York, NY: St. Martin's Press; 1987.
14. Chitwood DD, Page JB, Comerford M, Inciardi JA, McCoy CB, Trapido E, et al. The donation and sale of blood by intravenous drug users. Am J Public Health. 1991;81:631-633.
15. Nelson KE, Vlahov D, Margolick J, Bernal M, Taylor E. Blood and plasma donations among a cohort of intravenous drug users. JAMA. 1990;263:2194-2197.
16. Domen RE. The ethics of paid versus volunteer blood donation. J Med Ethics. 1994;20:269-270.
17. Kretzmann MJ. Bad blood: the moral stigmatisation of paid plasma donors. J Contemp Ethnogr. 1992; 20:4:416-441.
18. Listing of source plasma location. Plasma Q. June 1980:46-62.
19. 1981 listing of source plasma licensed locations. Plasma Q. June 1981:42-59.
20. 1982 listing of source plasma licensed locations. Plasma Q. Summer 1982:46-63.
21. 1983 listing of source plasma FDA licensed locations. Plasma Q. Spring 1983:48-64.
22. 1986 listing of source plasma locations. Plasma Q. 1986:53-62.
23. 1987 listing of source plasma locations. Plasmapheresis. July/August 1987:9-27.
24. 1988 listing of source plasma locations. PLASMApheresis. June 1988:158-168.
25. 1989 listing of source plasma locations. PLASMApheresis. June 1989:160-170.
26. 1990 listing of source plasma locations. PLASMApheresis. Fall 1990:72-82.
27. Source plasma collection facilities. J Am Blood Resour Assoc. 1995;4(1):21-31.
28. Felman YM. Sexually transmitted disease control services in a jail population: analysis and recommendations. Bull N Y Acad Med. 1982;58:559-567.
29. Barton WI. Drug histories and criminality of inmates of local jails in the United States (1978): implications for treatment and rehabilitation of the drug abuser in a jail setting. Int J Addict. 1982;17:417-444.
30. Koplan JP, Walker JA, Bryan JA, Berquist KR. Prevalence of hepatitis B surface antigen and antibody at a state prison in Kansas. J Infect Dis. 1978;137: 505-506.
31. US Bureau of the Census. Geographic Areas Reference Manual. Washington, DC: US Bureau of the Census; 1994.
32. White MJ. American Neighborhoods and Residential Differentiation. New York, NY: Russell Sage Foundation; 1987.
33. US Bureau of the Census. 1980 Census of Population and Housing. Summary Tape File 3A (STF 3A). Washington, DC: US Department of Commerce, Bureau of the Census; 1980.
34. US Bureau of the Census. 1990 Census of Population and Housing. Summary Tape File 3A (STF 3A). Washington, DC: US Department of Commerce, Bureau of the Census; 1990.
35. Ricketts E, Sawhill IV. Defining and measuring the underclass. J Policy Anal Manage. 1988;7:316-325.
36. Substance Abuse and Mental Health Services Administration. National Household Survey on Drug Abuse: Public Release Codebook 1993. Rockville, Md: US Department of Health and Human Services; 1995.
37. Wilson WJ. Studying inner-city social dislocations: the challenge of public agenda research. Am Social Rev. 1991;56:1-14.
38. Sampson RJ, Groves WB. Community structure and crime: testing social-disorganization theory. Am J Sociol. 1989;94:774-802.
39. Sampson RJ, Raudenbush SW, Earls F. Neighborhoods and violent crime: a multilevel study of collective efficacy. Science. 1997;277:918-924.
40. James R. The Location of Source Plasma Clinics in the United States: 1980-1995. A Social Epidemiology Perspective [dissertation]. Winnipeg: University of Manitoba; 2002.
41. Saxe L, Kadushin C, Beveridge A, Livert D, Tighe E, Rindskopf D, et al. The visibility of illicit drugs: implications for community-based drug control strategies. Am J Public Health. 2001;91:1987-1994.
42. Geronimus AT, Bound J, Neidert LJ. On the validity of using census geocode characteristics to proxy individual socioeconomic characteristics. J Am Stat Assoc. 1996;91:529-537.
43. Geronimus AT, Bound J. Use of census-based aggregate variables to proxy for socioeconomic group: evidence from national samples. Am J Epidemiol. 1998; 148:475-486.